## Abstract ## Background Bisphosphonates are known to be associated with osteonecrosis of the jaw. We assess factors underlying the success of surgical treatment in patients with bisphosphonate‐related osteonecrosis of the jaw (BRONJ). ## Methods Fifty‐eight patients were investigated 6 months
Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws
✍ Scribed by Thomas Mücke; Janett Koschinski; Herbert Deppe; Stefan Wagenpfeil; Christoph Pautke; David A. Mitchell; Klaus-Dietrich Wolff; Frank Hölzle
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 336 KB
- Volume
- 137
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background. Osteonecrosis of the jaws occurs after the administration of bisphosphonates. An unequivocal treatment strategy is yet to be devised. We assess the treatment of patients with bisphosphonate‐related osteonecrosis of the jaws (BRONJ). ## Methods. The investigators studie
We read with great interest the article by Wutzl et al, 1 reporting a well-designed prospective study for the treatment of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in a cohort of multiple myeloma, breast cancer, and other diseases in patients. The authors duly report patients' under
## Abstract ## Background and Objectives This preliminary report describes a new laser‐assisted treatment option for the emerging complication of bisphosphonate related osteonecrosis (BON) of the jaw. ## Materials and Methods In eight tumour patients (three women, five men) ten bony lesions in t